Join
Live feed
·
PRReleasevia Quantisnow
Guardant Health Inc. logo

Guardant Health to Present 14 Abstracts Demonstrating the Power of Multiomic Liquid Biopsy Tests in Predicting Outcomes and Tailoring Treatment for Early and Metastatic Breast Cancer at the 2025 San Antonio Breast Cancer Symposium

ByQuantisnow·Wall Street's wire, on your screen.
GH· Guardant Health Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GH (Guardant Health Inc.) and more on Quantisnow.